Benzinga's Top Upgrades, Downgrades For October 12, 2018

Top Upgrades

• Citigroup upgraded Netflix, Inc. NFLX from Neutral to Buy. Netflix shares rose 4.33 percent to $335.00 in pre-market trading.
• Pivotal Research upgraded Snap Inc SNAP from Hold to Buy. Snap shares rose 4.9 percent to $7.14 in pre-market trading.
• Wedbush upgraded Fitbit Inc FIT from Neutral to Outperform. Fitbit shares rose 6.2 percent to $4.78 in pre-market trading.
• Stifel Nicolaus upgraded Marvell Technology Group Ltd. MRVL from Hold to Buy Marvell Technology shares rose 2.8 percent to $18.22 in pre-market trading.
• JP Morgan upgraded Eastman Chemical Company EMN from Neutral to Overweight. Eastman Chemical shares fell 2.59 percent to close at $82.05 on Thursday.
• Pivotal Research upgraded Twitter Inc TWTR from Sell to Hold. Twitter shares rose 2.5 percent to $27.67 in pre-market trading.
• Macquarie upgraded Microsoft Corporation MSFT from Neutral to Outperform. Microsoft shares rose 2.8 percent to $108.82 in pre-market trading.
• Stifel Nicolaus upgraded RH RH from Hold to Buy. RH shares rose 4.5 percent to $123.90 in pre-market trading.
• Analysts at Canaccord Genuity upgraded Square Inc SQ from Hold to Buy. Square shares rose 8.2 percent to $74.70 in pre-market trading.

Top Downgrades

• JP Morgan downgraded Estee Lauder Companies Inc EL from Overweight to Neutral. Estee Lauder shares rose 0.5 percent to $128.70 in pre-market trading.
• Jefferies downgraded Molina Healthcare, Inc. MOH from Buy to Hold. Molina Healthcare shares closed at $138.79 on Thursday.
• Longbow Research downgraded Masco Corp MAS from Buy to Neutral. Masco shares rose 0.8 percent to $32.85 in pre-market trading.
• Bank of America downgraded CMS Energy Corporation CMS from Buy to Neutral. CMS Energy shares fell 2.13 percent to close at $49.21 on Thursday.
• JP Morgan downgraded Diamond Offshore Drilling Inc DO from Neutral to Underweight. Diamond Offshore shares gained 0.4 percent to $19.23 in pre-market trading.
• Mizuho downgraded Alder Biopharmaceuticals Inc ALDR from Buy to Neutral. Alder BioPharmaceuticals shares closed at $13.40 on Thursday.
• JP Morgan downgraded Genesee & Wyoming Inc GWR from Overweight to Neutral. Genesee & Wyoming shares gained 0.5 percent to $82.82 in pre-market trading.
• Longbow Research downgraded Fortune Brands Home & Security Inc FBHS from Buy to Neutral. Fortune Brands Home & Security shares fell 2.22 percent to close at $48.00 on Thursday.

Top Initiations

• Nomura initiated coverage on IAC/InterActiveCorp IAC with a Buy rating. The price target for IAC/InterActiveCorp is set to $246. IAC/InterActiveCorp shares closed at $193.20 on Thursday.
• Analysts at Bernstein initiated coverage on Sarepta Therapeutics Inc SRPT with an Outperform rating. The price target for Sarepta Therapeutics is set to $170. Sarepta shares closed at $122.01 on Thursday.
• Analysts at Stifel Nicolaus initiated coverage on Chaparral Energy Inc CHAP with a Buy rating. The price target for Chaparral Energy is set to $23. Chaparral Energy shares closed at $16.22 on Thursday.
• Analysts at Nomura initiated coverage on Match Group Inc MTCH with a Buy rating. The price target for Match Group is set to $66. Match Group closed at $51.40 on Thursday.
• Credit Suisse initiated coverage on Honeywell International Inc. HON with a Neutral rating. The price target for Honeywell is set to $170. Honeywell closed at $153.62 on Thursday.
• Morgan Stanley initiated coverage on Advanced Disposal Services Inc ADSW with an Equal-Weight rating. The price target for Advanced Disposal is set to $27. Advanced Disposal shares closed at $25.79 on Thursday.
• Buckingham initiated coverage on MSC Industrial Direct Co Inc MSM with a Neutral rating. The price target for MSC Industrial Direct is set to $89. MSC Industrial Direct shares closed at $79.62 on Thursday.
• Credit Suisse initiated coverage on Acuity Brands, Inc. AYI with a Neutral rating. The price target for Acuity Brands is set to $135. Acuity Brands shares closed at $119.44 on Thursday.
• Bank of America initiated coverage on Chemed Corporation CHE with a Buy rating. The price target for Chemed is set to $390. Chemed shares closed at $297.83 on Thursday.